People Who Are Overweight Or Obese In Middle Age May Be Less Likely To Develop Dementia Than Normal Weight, Underweight Peers.

Posted · Add Comment

HealthDay¬†(4/10, Reinberg) reports that a study published online April 10 in The Lancet Diabetes & Endocrinology suggests that people ‚Äúwho are overweight or obese in middle age may be less likely to develop dementia than their normal and underweight peers.‚ÄĚ The study, which included almost two million people, revealed that ‚Äúoverweight and obese people were [...]

Report: Some Alzheimer’s Patients Not Told By Medical Professionals Of Their Diagnosis

Posted · Add Comment

The Wall Street Journal (3/24, D2, Beck, Subscription Publication) reports that the Alzheimer’s Association says that about 55 percent of people with Alzheimer’s and those who look after them may never have learned from their physician that they have the disease. The Washington Post (3/24, Kunkle) reports that in its annual report, the association found that “medical professionals are [...]

Long-Term Study Of Medicine To Prevent Alzheimer’s Raises Questions

Posted · Add Comment

The Arizona Republic (2/23, Alltucker) reports in a 3,900-word article in a series focusing on Colombians with an inherited form of early onset Alzheimer’s caused by the paisa mutation that if crenezumab, the medication being used in a long-term study, is successful in preventing Alzheimer’s in this population, “the question becomes how would it attack the more [...]

Alzheimer’s Researchers Focus On Paisa Mutation Carriers.

Posted · Add Comment

In a 3,800-word article, the¬†Arizona Republic¬†(2/15, Alltucker) reported that scientists are studying families in the Medellin and District of Antioquia areas of Colombia who suffer from early onset Alzheimer‚Äôs. Almost 20 years ago, researchers ‚Äútraced the cause to a single genetic mutation passed from generation to generation.‚ÄĚ That mutation is known as the paisa mutation. [...]

High Dose and Extended Use of Anticholinergic Drugs May Increase Risk for Dementia, Study Suggests

Posted · Add Comment

Previous studies have suggested that medicines‚ÄĒboth prescription and over-the-counter‚ÄĒaiming to block the actions of acetylcholine may be associated with increased risk for cognitive impairment, but a new¬†studypublished this week in¬†JAMA Internal Medicine¬†shows that use of such medicines in older adults may increase risk for dementia. Researchers from the Geriatric Pharmacy Program at the University of [...]

Amyloid and Anxiety May Speed Cognitive Decline in Preclinical Alzheimer’s, Study Suggests

Posted · Add Comment

High levels of anxiety concurrent with elevated amyloid beta (Aő≤) levels in the brain were significantly associated with cognitive decline in healthy older adults, according to a¬†report¬†in¬†JAMA Psychiatry. The results suggest that the combination could be crucial during the long preclinical phase of Alzheimer‚Äôs disease (AD). AD is known to have a preclinical phase in [...]

Researchers To Begin Trials Of Potential Alzheimer’s Treatment

Posted · Add Comment

The¬†Boston Herald¬†(1/14, Kalter) reports that researchers at Boston University ‚Äúare testing a pill,‚ÄĚ called T-817MA, ‚Äúthat could protect the brain against the ravages of Alzheimer‚Äôs disease.‚ÄĚ Dr. Robert Stern, Boston University‚Äôs principal investigator for the trial, said, ‚ÄúThe goal of this new medication going into clinical trials is really to try and slow down the [...]

People Turn To Unique Prevention Clinic To Fend Off Alzheimer’s

Posted · Add Comment

NBC Nightly News¬†(12/16, story 7, 2:25, Williams) reported, ‚ÄúCases of Alzheimer‚Äôs continue to grow in this country. More than five million Americans are living with it, and we‚Äôre told that number‚Äôs expected to triple by 2050.‚ÄĚ The focus now turns to prevention because some ‚Äúbrain changes leading to Alzheimer‚Äôs can start as early as 20 [...]

Alzheimer’s Medicine Shows Early Positive Results

Posted · Add Comment

The Wall Street Journal (12/3, Whalen, Subscription Publication) reports that Biogen Idec Inc. has announced positive interim results from an early-stage study of its medication, BIIB037, to treat Alzheimer’s. The results showed that after 54 weeks of treatment, the treatment had reduced beta amyloid levels in the brain and improved cognition when compared with the placebo among [...]

Study: More Than Half Of Americans With Dementia Have Never Undergone Thinking, Memory Screening

Posted · Add Comment

HealthDay¬†(11/27, Preidt) reported that research¬†published online¬†(12/1) in Neurology suggests that ‚Äúmore than half of Americans with dementia have never undergone screening of their thinking and memory skills.‚ÄĚ The research ‚Äúincluded almost 300 people with dementia, aged 70 and older, who were taking part in the national Health and Retirement Study.‚ÄĚ The¬†Medscape¬†(12/1) reported that investigators ‚Äúfound [...]